ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Premium IconPremium Help Menu
S&P 500
5,525.21
0.74%
Dow Jones
40,113.50
0.05%
US Dollar vs MXN
19.534
0.15%
Brent Oil
65.935
-0.14%
Bitcoin
93,751.50
0.00%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) Noticias

HRTX

Heron Therapeautics (HRTX)

Heron Therapeautics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HRTX
FechaHoraFuenteTítuloSímboloCompañía
22/04/202515:05PR Newswire (US)Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025NASDAQ:HRTXHeron Therapeautics Inc
22/04/202509:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
27/02/202506:45Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:HRTXHeron Therapeautics Inc
27/02/202506:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
27/02/202506:45PR Newswire (US)Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
13/02/202515:20PR Newswire (US)Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025NASDAQ:HRTXHeron Therapeautics Inc
04/02/202516:40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
23/12/202415:05PR Newswire (US)Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North CarolinaNASDAQ:HRTXHeron Therapeautics Inc
04/12/202407:45AllPennyStocks.comWall Street Analysts Were Busy This MorningNASDAQ:HRTXHeron Therapeautics Inc
03/12/202415:36PR Newswire (US)U.S. District Court Upholds Validity of CINVANTI® PatentsNASDAQ:HRTXHeron Therapeautics Inc
12/11/202406:55PR Newswire (US)Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial GuidanceNASDAQ:HRTXHeron Therapeautics Inc
05/11/202411:41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
04/11/202416:00PR Newswire (US)Heron Therapeutics Announces Appointment of Michael Kaseta to Board of DirectorsNASDAQ:HRTXHeron Therapeautics Inc
29/10/202415:05PR Newswire (US)Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024NASDAQ:HRTXHeron Therapeautics Inc
24/10/202413:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:HRTXHeron Therapeautics Inc
10/10/202415:08PR Newswire (US)Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous FluidsNASDAQ:HRTXHeron Therapeautics Inc
25/09/202407:00PR Newswire (US)Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
03/09/202407:00PR Newswire (US)Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business OfficerNASDAQ:HRTXHeron Therapeautics Inc
06/08/202415:35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HRTXHeron Therapeautics Inc
06/08/202415:05PR Newswire (US)Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial GuidanceNASDAQ:HRTXHeron Therapeautics Inc
30/07/202415:05PR Newswire (US)Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024NASDAQ:HRTXHeron Therapeautics Inc
15/07/202407:00PR Newswire (US)Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment SystemNASDAQ:HRTXHeron Therapeautics Inc
02/07/202407:00PR Newswire (US)Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
31/05/202410:08Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
29/05/202407:05PR Newswire (US)Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
07/05/202407:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HRTXHeron Therapeautics Inc
07/05/202407:00PR Newswire (US)Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
24/04/202407:00PR Newswire (US)Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NASDAQ:HRTXHeron Therapeautics Inc
11/04/202415:05PR Newswire (US)Heron Therapeutics to Host Investor Day on May 15, 2024 in New York CityNASDAQ:HRTXHeron Therapeautics Inc
28/03/202415:05PR Newswire (US)Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:HRTXHeron Therapeautics Inc
 Showing the most relevant articles for your search:NASDAQ:HRTX

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
AMEX
XLV
Health Care Select Sector
FX
USDMXN
US Dollar vs MXN
NYSE
XOM
Exxon Mobil
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
FX
EURMXN
Euro vs MXN
NYSE
MRK
Merck
NASDAQ
AAPL
Apple
SPI
SP500
S&P 500
NASDAQ
MSFT
Microsoft
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
AVAXUSD
Avalanche
USOTC
ADDYY
Adidas (QX)
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios